At the Forefront of Care: 21 RCCA Physicians Recognized as 2022 Top Cancer Doctors by Castle Connolly

Compassion, skill, collaboration, leadership, knowledge. These are just a few of the things that set some physicians apart from the rest, and they are qualities commonly found in those at the forefront of their field.

This year, 21 doctors from Regional Cancer Care Associates, or RCCA, were recognized for having these traits and other distinctive attributes when they were named 2022 Top Cancer Doctors in New Jersey by health care research and information company Castle Connolly. The company long has been America’s trusted source for identifying top doctors through its exhaustive and independent process of peer nomination, research, review and screening.

These physicians exemplify what it means to protect and enhance health. They apply their expertise to lead patients through medical challenges, lead their profession to new heights of effective care, and lead their fellow clinical team members to greater collaboration. They embody excellence in their medical specialty, representing the best of the best in terms of their skill, professionalism and patient-centered focus.

The 21 RCCA physicians named to Castle Connolly’s prestigious list of 2022 Top Cancer Doctors in New Jersey are:

May Abdo-Matkiwsky, DO, serving the Sparta community

Kaleen Ahmad, MD, serving the Cape May Court House/Marmora community

Seth Berk, MD, serving the Moorestown community

Andrew Bernstein, DO, serving the Pompton Plains community

Maurice Cairoli, MD, serving the Moorestown community

Jumana Chatiwala, MD, serving the Sparta community

Michele Donato, MD, serving the Hackensack community

Tatyana Feldman, MD, serving the Hackensack community

Denis Fitzgerald, MD, serving the Little Silver community

Glen Gejerman, MD, serving the Hackensack community

Andre Goy, MD, serving the Hackensack community

Harry Harper, MD, serving the Hackensack community

Anthony Ingenito, MD, serving the Hackensack community

Andrew Jennis, MD, serving the Hackensack/North Bergen community

James Lee, MD, serving the Moorestown community

Mark Pascal, MD, serving the Franklin Lakes/Hackensack community

Andrew Pecora, MD, serving the Hackensack/North Bergen community

Scott Rowley, MD, serving the Hackensack community

Ami Vaidya, MD, serving the Hackensack community

Stanley Waintraub, MD, serving the Hackensack community

Stephen Wallace, MD, serving the Moorestown community

Of the more than 850,000 practicing physicians in the U.S., just 7% are named to the Top Doctors list. The designation is conferred only after a rigorous vetting process conducted by an experienced medical review board. Reviewers consider each doctors’ skills, professionalism, training/qualifications, experience, competence, outcomes and achievements as well as his or her relational skills and empathy toward patients.

RCCA has 90-plus cancer specialists who treat patients at more than 25 RCCA care centers in New Jersey, Connecticut, Maryland and the Washington, D.C., area. Those oncologists see more than 23,000 new patients each year and provide care to more than 225,000 established patients, collaborating closely with their patients’ other physicians. They offer patients the latest in cutting-edge treatments, including immunotherapies and targeted therapy, as well as access to a wide range of clinical trials. In addition to serving patients who have solid tumors, blood-based cancers, and benign blood disorders such as anemia, RCCA care centers also provide infusion services to people with a number of non-oncologic conditions—including multiple sclerosisCrohn’s diseaseasthma, and rheumatoid arthritis — who take intravenously-administered medications.

To learn more about RCCA, call 844-928-0089 or visit RCCA.com.  

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

RELATED ARTICLES

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.